Annovis Bio corrects proxy typo, restates Ernst & Young audit fees at $415,000 for 2025

Annovis Bio, Inc.

Correction fixes a typographical error in the audit-fee disclosure in the proxy statement for the annual meeting held June 17, 2026.
2025 Ernst & Young fees: audit $415,000, audit-related $100,000, total $515,000.
2024 Ernst & Young fees: audit $375,000, audit-related $107,045, total $482,045.
No tax fees or all-other fees were reported in either 2025 or 2024; no change of auditor disclosed.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.